Project Grant F30DK149444
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University $720,353 on March 25, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Assistance Listing Project Grant R01DK141555). The award funds research to identify and elucidate the functioning of hypothalamic neural circuits that regulate energy balance and metabolism, with focus on obesity-associated metabolic diseases. The research targets a...
- The National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health under the Department of Health and Human Services, awarded $717,030 to the University of Virginia on May 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to uncover neural circuits controlling body weight and metabolism. The research develops and applies RAMPANT (rabies afferent mapping by poly-A nuclear transcriptomics), a novel...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The University of Chicago $123,000 on June 16, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to characterize adipocyte heterogeneity and response to metabolic stress. The funded research uses single-nucleus RNA sequencing and a humanized mouse model to investigate how diverse stimuli influence white adipocyte development and specification, with emphasis on...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Washington $888,773 on April 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant R01DK140210). The award funds research defining the contributions of hypothalamic microglia and perineuronal nets to obesity pathogenesis. The project investigates inflammatory activation of hypothalamic microglia in the arcuate nucleus and the loss of...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Trustees of Columbia University in the City of New York $1,563,913 on September 11, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support research on vascular sympathetic neurons in brown adipose tissue and their role in systemic metabolism. The recipient will develop and deploy novel mouse genetic and chemogenetic tools, improved imaging techniques, and in...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Medical College of Wisconsin, Inc. $406,985 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate mechanisms regulating FOXA1 and FOXA2 transcription factors during human liver development. The research addresses how FOXA1 and FOXA2 pioneer transcription factors regulate chromatin opening and gene activation required for hepatic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Midwestern University $710,812 on April 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the role of intrinsic primary afferent neurons in intestinal nutrient sensing and obesity. The research uses molecular, behavioral, and electrophysiological approaches to uncover how intestinal sensory neurons modulate glucose absorption, lipid transport, and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of California, Los Angeles $167,363 on March 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support basic and clinical biomedical research on novel central nervous system mechanisms in obesity. The award funds research investigating how the paraventricular nucleus of the hypothalamus integrates nutrient-related cues to control peripheral energy and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Illinois $786,728 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to characterize gut microbiota-derived metabolic signaling pathways that regulate thermogenic fat cell formation and energy homeostasis in obesity. The funded research investigates 3-phenylpropionic acid (3-PPA), a gut microbiota-derived metabolite, as a promoter of beige...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Georgia State University Research Foundation Inc. $715,511 on August 25, 2026, to support basic research on the epigenetic regulation of sympathetic nerve innervation in adipose tissue under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funded research investigates how DNA methylation reprograms sympathetic nervous system innervation in response to environmental cues such as...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Medical College of Wisconsin, Inc. $108,968 on February 17, 2027, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate neural mechanisms governing resting metabolic rate and cardiovascular function. The research focuses on cardiometabolic control by angiotensin II type 1 receptor-expressing agouti-related peptide neurons in the arcuate nucleus of the hypothalamus. The project examines how diet-induced obesity causes a G protein signaling switch in these neurons, altering angiotensin II signaling from inhibitory to stimulatory, and tests the hypothesis that this obesity-induced plasticity represents a maladaptive mechanism contributing to impaired metabolic homeostasis and dysregulation of both resting metabolic rate and blood pressure. Two specific aims address the contribution of type 1 agouti-related peptide neurons to cardiometabolic control in lean animals and the functional consequences of obesity-induced signaling plasticity in this neuronal population. Performance occurs in Wauwatosa, Wisconsin. The award runs through August 31, 2030. This project grant supports basic and clinical biomedical research under the National Institutes of Health's program to improve understanding of mechanisms underlying diabetes, digestive, and kidney diseases and to advance prevention, diagnosis, and treatment approaches.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $54.5k | 8/17/26 | ||
| Not listed | $0 | 8/17/26 |